Showing results (91-100 of 162) with videos related to
Sort By:
Pageof 17
Complement (Basel, Switzerland)|January 1, 1986
Decreased expression of C3b receptor (CR1) on erythrocytes of patients with systemic lupus erythematosus contrasts with its normal expression in other systemic diseases and does not correlate with the occurrence or severity of SLE nephritisM H Jouvin, J G Wilson, P Bourgeois, et al.The Journal of Experimental Medicine|January 1, 1996
A subpopulation of B220+ cells in murine bone marrow does not express CD19 and contains natural killer cell progenitorsA Rolink, E ten Boekel, F Melchers, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1984
Inhibition of the function of activated properdin by squid chondroitin sulfate E glycosaminoglycan and murine bone marrow-derived mast cell chondroitin sulfate E proteoglycanJ G Wilson, D T Fearon, R L Stevens, et al.The Journal of Experimental Medicine|December 1, 1991
Determination of the structural basis for selective binding of Epstein-Barr virus to human complement receptor type 2D R Martin, A Yuryev, K R Kalli, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1988
Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytesR H Carter, M O Spycher, Y C Ng, et al.Annual Review of Immunology|January 1, 1996
Somatic hypermutation of immunoglobulin genesS D Wagner, M S NeubergerSurgery|September 1, 1987
Neutrophil activation after burn injury: contributions of the classic complement pathway and of endotoxinC F Davis, F D Moore, M L Rodrick, et al.The Journal of Experimental Medicine|March 28, 1998
Inhibition of the B cell by CD22: a requirement for LynK G Smith, D M Tarlinton, G M Doody, et al.Journal of Immunological Methods|October 10, 1985
Rapid purification of the human C3b/C4b receptor (CR1) by monoclonal antibody affinity chromatographyW W Wong, R M Jack, J A Smith, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1991
The CD19 complex of B lymphocytes. Activation of phospholipase C by a protein tyrosine kinase-dependent pathway that can be enhanced by the membrane IgM complexR H Carter, D A Tuveson, D J Park, et al.Pageof 17